In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Among patients with type 2 diabetes, no differences were found with biguanides vs DPP-4 inhibitors in major cardiac or cerebrovascular events, diabetic complications, or death. Biguanides vs ...

Among patients with type 2 diabetes, no differences were found with biguanides vs DPP-4 inhibitors in major cardiac or cerebrovascular events, diabetic complications, or death. Biguanides vs ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

Su Yu-cheng (right)shares his experience of serving as the flag bearer for the Chinese Kendo team during the opening ceremony ...

It seems like a day doesn’t go by without another positive finding for the glucagon-like peptide 1 (GLP-1) receptoragonist ...

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

Chinese experts have vehemently slammed the recent false claim by the Democratic Progressive Party (DPP) authorities that the ...